Overview
Organ transplantation is the process of taking a graft — a cell, tissue, or organ — from one site (or individual, the donor) and placing it at another site (or into another individual, the recipient) to restore lost function. While the earliest reference to grafting dates back to Sushruta Samhita (circa 800 BC) for skin grafts, modern transplantation began in the 1950s–60s with successful kidney and liver transplants.
Immunology is central to transplantation success — the recipient's immune system can recognise a graft as foreign and reject it. Understanding transplantation antigens (MHC, HLA), rejection mechanisms, and immunosuppressive strategies is essential for laboratory professionals involved in tissue typing and transplant medicine.
Learning Objectives
After this lesson you will be able to…- Define transplantation and describe its history
- Describe the various types of grafts (autograft, isograft, allograft, xenograft)
- Explain the immunologic basis of allograft rejection
- Discuss the classification and effector mechanisms of allograft rejection (HVGR, GVHD)
- Describe basic strategies for prevention and treatment of allograft rejection
- Define xenotransplantation
Clinical Story
Why This MattersA 45-year-old man with end-stage renal disease is scheduled to receive a kidney from his brother. Before the surgery can proceed, the laboratory must perform ABO/Rh typing, crossmatching, and HLA typing to confirm compatibility between donor and recipient — the accuracy of this tissue typing work directly determines whether the transplant will succeed or trigger rejection.
Core Concepts
Autograft: tissue moved within the same individual (e.g. skin grafting for burns). Isograft: between genetically identical individuals of the same species (e.g. identical twins). Allograft: between genetically different individuals of the same species (e.g. kidney from son to father). Xenograft: between different species (e.g. pig heart valve in a human).
By site: Orthotopic (graft at the normal anatomical location, e.g. liver, heart) vs Heterotopic (graft at a different location, e.g. kidney, pancreas). By source: Live donor graft vs Cadaveric (after death) donor graft.
First set rejection: the first graft from a donor is initially accepted (vascularised, normal), but by day 4 lymphocytic infiltration and ischaemia begin, and the graft sloughs off by day 10. Second set rejection: a repeat graft from the same donor is rejected faster (by day 6) due to immunological memory from the first exposure.
Host versus Graft Reaction (HVGR): the host rejects the graft — classified as hyperacute (minutes), acute (days–2 weeks), or chronic (months–years) rejection. Graft versus Host Reaction/Disease (GVHR/GVHD): an immunologically active graft (e.g. bone marrow) reacts against the host's tissues, seen in bone marrow and immune cell transplantation.
Laboratory Principle
Graft rejection is fundamentally an immune response against transplantation antigens — Major Histocompatibility Complex (MHC) molecules, Minor histocompatibility (HLA) antigens, and other alloantigens like ABO blood group. Recipient T cells recognise the donor's allogeneic MHC molecules as foreign, triggering cell-mediated immunity; humoral immunity (complement activation, antibody-dependent cytotoxicity) and NK cell activation also contribute. Laboratory tissue typing (ABO/Rh typing, crossmatching, HLA-A/B/DR typing) is performed pre-transplant to identify the most compatible donor-recipient pair and minimise the risk of rejection.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Anti-A, Anti-B, Anti-D antisera | Blood banking grade | ABO and Rh typing of donor and recipient | 2–8°C |
| HLA typing reagents (SSP/SSO kits) | Kit-specific | HLA-A, -B, -DR typing | -20°C or per kit |
| Donor lymphocytes and recipient serum | Fresh | Crossmatching (detect preformed antibodies) | Use fresh; process promptly |
| Immunosuppressive drugs (reference standards) | Cyclosporine, azathioprine, etc. | Therapeutic drug monitoring | Per drug-specific storage requirements |
Step-by-Step Procedure
Determine ABO and Rh blood group of both donor and recipient — a fundamental compatibility check before any further testing.
Test recipient serum against donor lymphocytes to detect preformed antibodies that could cause hyperacute rejection.
Perform HLA-A, HLA-B, and HLA-DR typing on both donor and recipient to assess the degree of histocompatibility match.
Combine ABO/Rh, crossmatch, and HLA typing results to determine suitability of the donor-recipient pair for transplantation.
After transplantation, monitor for signs of rejection and therapeutic drug levels of immunosuppressive agents to guide dose adjustment.
Flow Diagram
Quality Control
All blood typing and crossmatch testing should include known positive and negative controls. HLA typing should be validated with reference cell panels to confirm accuracy of allele calling before results are released for clinical decision-making.
Transplant immunology laboratories should participate in national/international proficiency testing programs for HLA typing and crossmatching to ensure accuracy given the high clinical stakes involved.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Positive crossmatch | Preformed antibodies against donor antigens — high risk of hyperacute rejection | Contraindicated for transplant with this donor; seek alternative donor |
| Well-matched HLA typing | Lower risk of rejection, better graft survival | Favourable for proceeding with transplant |
| Signs of graft dysfunction post-transplant | May indicate acute or chronic rejection | Biopsy and adjust immunosuppressive therapy as indicated |
Common Errors & How to Avoid Them
Cause: Inadequate sensitivity of the crossmatch technique or technical error can fail to detect preformed antibodies.
Prevention: Use validated, sufficiently sensitive crossmatch methods (e.g. flow cytometric crossmatch) and repeat testing when results are borderline.
Cause: Sample mislabeling or transcription errors in blood typing.
Prevention: Follow strict positive patient identification and sample labelling protocols; repeat typing on a second independent sample.
Cause: Low-resolution typing methods may miss clinically significant allele mismatches.
Prevention: Use high-resolution molecular typing (e.g. SSP/SSO/NGS) when precise matching is critical, particularly for bone marrow transplantation.
Laboratory Tips from the Bench
Always confirm ABO compatibility before proceeding to more complex and expensive HLA typing/crossmatch tests — an ABO mismatch alone can rule out a donor.
Remember that bone marrow and stem cell transplants carry a unique risk — graft-versus-host disease — because the graft itself contains immunocompetent cells capable of attacking the host.
"A-I-A-X" for graft types by species: Autograft (self), Isograft (identical twin), Allograft (same species, different genotype), Xenograft (different species).
Important Notes
Despite ongoing research into transplanting organs from animal species (e.g. pig heart) into humans, no successful, routine clinical xenotransplantation has yet been achieved due to strong immunological barriers.
Alexis Carrel (1912, vascular suture), Peter Medawar (1960, immunological tolerance), Joseph Murray (1990, kidney transplantation), and Elion/Hitchings (1988, immunosuppressant drugs) all won Nobel Prizes for foundational contributions to transplant science.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgeArjun has end-stage renal disease and is scheduled to receive a kidney donated by his brother. Pre-transplant tissue typing is ordered to assess compatibility before surgery.
ABO/Rh compatibility and a negative crossmatch indicate no immediate barrier to transplantation and low risk of hyperacute rejection. A 4/6 HLA match, while not perfect, is considered reasonably favourable for a living related donor transplant and the transplant may proceed with standard immunosuppressive therapy.
- →ABO compatibility and a negative crossmatch are prerequisites before considering HLA match quality.
- →A perfect HLA match is not always required, especially for living related donors.
- →Post-transplant immunosuppression and monitoring remain essential even with a favourable match.
Frequently Asked Questions
ABO mismatch can cause hyperacute rejection within minutes due to preformed anti-A/anti-B antibodies. It is a fundamental, simpler test that quickly rules out clearly incompatible donors before investing in more complex and costly HLA typing.
HVGR is when the host's immune system attacks and rejects the transplanted graft (seen in conventional solid organ transplants). GVHD is the reverse — when immunocompetent cells within the graft (e.g. bone marrow) attack the host's own tissues.
Xenotransplantation remains largely experimental. While research continues (e.g. genetically modified pig organs), no fully successful, routine clinical application has yet been achieved due to strong immunological barriers between species.
Quick Revision
10-Minute ReviewKey Takeaways
- Transplantation moves a graft from a donor site/individual to a recipient site/individual to restore function.
- Grafts are classified by species (autograft, isograft, allograft, xenograft), by site (orthotopic, heterotopic), and by source (live, cadaveric).
- Graft rejection is an immune response driven mainly by T cell recognition of donor MHC/HLA antigens.
- HVGR (host rejects graft) and GVHD (graft attacks host) represent opposite directions of immune attack in transplantation.
- Tissue typing (ABO/Rh, crossmatch, HLA typing) minimises rejection risk before transplantation.
- Immunosuppressive therapy and induction of immune tolerance are key strategies to prevent and treat rejection.
Competency Checklist
Track Your MasteryReferences
- NIOS Microbiology Module — Lesson 65: Organ Transplantation.
- Sushruta Samhita (circa 800 BC) — historical reference to skin grafting.
- Standard textbooks of Medical Microbiology and Immunology (Ananthanarayan & Paniker; Baveja).